Key result
Corosolic acid reduces acute myocardial injury in diabetic rats by limiting myonecrosis and elevating PPAR-γ.
Why the study?
To determine whether corosolic acid could protect the myocardium of diabetic rats from isoproterenol-induced damage and assess the potential role of PPAR-γ activation.
Does corosolic acid protect the myocardium from isoproterenol-induced damage in diabetic rats?
Does corosolic acid protect the myocardium from isoproterenol-induced damage in diabetic rats?
Corosolic acid ameliorates isoproterenol-induced acute myocardial injury in diabetic rats, potentially via the PPAR-γ pathway.
No takes yet. Share an insight, caveat, or question.
Should not change practice; leaves open translation of corosolic acid effects to human diabetic myocardial injury.
Alkholifi et al. (2023) studied Isoproterenol-induced myocardial damage in diabetes. Corosolic acid vs. Diabetic control, GW9662, and corosolic acid plus GW9662 was evaluated on Myocardial damage (myonecrosis, edema, lipid peroxidation, antioxidant levels). Corosolic acid ameliorated isoproterenol-induced acute myocardial injury in diabetic rats by reducing myonecrosis, edema, and lipid peroxidation, and elevating PPAR-γ expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: